Glucotrack, Inc. (GCTK) stock
GCTKOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.68−0.04 (-5.56%)
Close on Oct 19, 2026Market cap $3.43MP/E 0.0Yield –
Glucotrack net income
Net income is the profit left for shareholders after every expense, interest and tax.
Glucotrack's net income for the twelve months ending Jun 30, 2026 was -$15.95M. For fiscal 2025 it was -$19.39M. The highest annual figure on record is $10.33M in fiscal 2017.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$19.39M | – |
| FY2024 | Dec 31, 2024 | -$22.60M | – |
| FY2023 | Dec 31, 2023 | -$7.10M | – |
| FY2022 | Dec 31, 2022 | -$4.44M | – |
| FY2021 | Dec 31, 2021 | -$4.07M | – |
| FY2020 | Dec 31, 2020 | -$2.70M | -176.7% |
| FY2019 | Dec 31, 2019 | $3.52M | – |
| FY2018 | Dec 31, 2018 | -$6.72M | -165.0% |
| FY2017 | Dec 31, 2017 | $10.33M | – |
| FY2016 | Dec 31, 2016 | -$5.41M | – |
| FY2015 | Dec 31, 2015 | -$5.84M | -296.0% |
| FY2014 | Dec 31, 2014 | $2.98M | – |
| FY2013 | Dec 31, 2013 | -$9.80M | – |
| FY2012 | Dec 31, 2012 | -$2.77M | – |
| FY2011 | Dec 31, 2011 | -$2.36M | – |
| FY2010 | Dec 31, 2010 | -$2.79M | – |
| FY2009 | Dec 31, 2009 | -$1.20M | – |
| FY2008 | Dec 31, 2008 | -$1.53M | – |
| FY2007 | Dec 31, 2007 | -$1.59M | – |
| FY2006 | Dec 31, 2006 | -$1.28M | – |
| FY2005 | Dec 31, 2005 | -$1.06M | – |
| FY2004 | Dec 31, 2004 | -$288.23K | – |
| FY2003 | Dec 31, 2003 | -$350.29K | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.81M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.33M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.63M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.17M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.76M | – |
| Q1 FY2025 | Mar 31, 2025 | -$6.83M | – |
| Q4 FY2024 | Dec 31, 2024 | -$10.09M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.09M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.49M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.93M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.41M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.22M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.18M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.29M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.29M | – |
| Q3 FY2022 | Sep 30, 2022 | -$928.00K | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.13M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.09M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.51M | – |
| Q3 FY2021 | Sep 30, 2021 | -$804.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$853.00K | – |
| Q1 FY2021 | Mar 31, 2021 | -$904.00K | – |
| Q4 FY2020 | Dec 31, 2020 | -$879.00K | -113.7% |
| Q3 FY2020 | Sep 30, 2020 | -$509.00K | – |
| Q2 FY2020 | Jun 30, 2020 | -$574.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$734.00K | – |
| Q4 FY2019 | Dec 31, 2019 | $6.43M | – |
| Q3 FY2019 | Sep 30, 2019 | -$996.78K | – |
| Q2 FY2019 | Jun 30, 2019 | -$898.86K | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.02M | -155.3% |
| Q4 FY2018 | Dec 31, 2018 | -$1.33M | -107.4% |
| Q3 FY2018 | Sep 30, 2018 | -$1.57M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.96M | – |
| Q1 FY2018 | Mar 31, 2018 | $1.85M | – |
| Q4 FY2017 | Dec 31, 2017 | $18.00M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.58M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.56M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.53M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.14M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.45M | – |
See a number that looks wrong?